BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32344015)

  • 1. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
    Markov SD; Gonzalez D; Mehla K
    Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1-NOX4 signaling axis regulates cancer cachexia.
    Dasgupta A; Shukla SK; Vernucci E; King RJ; Abrego J; Mulder SE; Mullen NJ; Graves G; Buettner K; Thakur R; Murthy D; Attri KS; Wang D; Chaika NV; Pacheco CG; Rai I; Engle DD; Grandgenett PM; Punsoni M; Reames BN; Teoh-Fitzgerald M; Oberley-Deegan R; Yu F; Klute KA; Hollingsworth MA; Zimmerman MC; Mehla K; Sadoshima J; Tuveson DA; Singh PK
    J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32441762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
    Bonetto A; Aydogdu T; Kunzevitzky N; Guttridge DC; Khuri S; Koniaris LG; Zimmers TA
    PLoS One; 2011; 6(7):e22538. PubMed ID: 21799891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
    Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
    Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
    Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
    Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
    Shukla SK; Dasgupta A; Mulder SE; Singh PK
    Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
    Wang Y; Sun X; Yang Q; Guo C
    Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.